Artemisia annua L. is a promising and potent antimalarial drug. This activity has been ascribed to its content of artemisinin, a sesquiterpene lactone that is stage specific and very effective against drug-resistant Plasmodium species and which has low toxicity. The in vitro antiplasmodial activity of artemisinin is enhanced by the flavonoids of the extract, as recently proposed by the authors. Different extracts (tinctures, infusions and decoctions), obtained from a cultivar selected by the University of Campinas (0.52% artemisinin), were analyzed in order to prove the selectivity of the solvents to obtain high yields of both artemisinin and flavonoids. Tinctures 40 and 60% v/v showed a greater power of extraction in comparison with infusions and decoctions. The best performance was obtained using 60% v/v tincture. The extraction efficiency for artemisinin was 40% and for flavonoids was 29.5%. Among aqueous extracts, the best results were obtained by preparing an infusion with boiling water, left to cool for 15 minutes before filtration. The extraction efficiency for artemisinin was 57.5% and for flavonoids was 8.2%. If leaves are boiled for several minutes the artemisinin concentration is decreased, probably due to the heat instability of this constituent. Also microwave could represent a valid alternative method to extract the phytocomplex, the extraction efficiency for artemisinin was 41.0% and that for flavonoids was 7.7%.
Artemisia annua L. (sweet or annual wormwood) is an annual herb endemic to the northern parts of Chahar and Suiyuan provinces in China, where it is known as 'quinghao' and has been used as a remedy for chills and fevers for more than 2000 years [1, 2] . Traditionally, the plant is used to prepare a drink, as indicated in the Compendium of Treatments (Ben Cao Gang Mu), written in 1596 AD by Li Shizhen: "take a handful of qinghao, soak it in a sheng (liter) of water, and squeeze out the juice and drink it all" [3, 4] . Nowadays the (daily) dose of A. annua given in the Chinese Pharmacopoeia for the treatment of various fevers, including malaria, is 4.5-9 g of dried plant material, extracted by heating with water [5, 6] . Surprisingly, only a few clinical studies based on the use of either extracts of the plant or traditional preparations are available. The first was carried out in 1992 in China: 144 malaria patients were treated with tablets containing either an ethanolic dried extract of A. annua or capsules using the same extract, but formulated in oil [7, 8] . Both treatments were found to be effective in reducing parasitaemia and fever at doses equivalent to 80.8 g (tablets) and 73.6 g (capsules) raw herb, given over a three-day period.
In the most recent literature, after development of high artemisinin-yielding plants (>0.5% per dried weight), clinical trials using either teas or decoctions have also been reported. The principal aim of such investigations is related to the possibility for populations in endemic areas with either scarce or no access to modern medicines or medical services to cultivate selected cultivars of A. annua and prepare either teas or decoctions from the plant material, achieving a positive effect in the treatment of malaria.
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An herbal tea prepared from a selected cultivar of A. annua with a high content of artemisinin (0.58% w/w dried herb) was evaluated in malaria patients in the Republic of Congo [9] . The dose was according to the recommendations of the Chinese Pharmacopoeia (5 g herbal drug/day for five days) and the extraction process was investigated in order to have the maximum extraction efficiency. It was proved that it is better to make an infusion rather than a short decoction (kept boiling for five minutes) in order to obtain the maximum extraction efficiency of more than 40%. In the study, about 90.9% of patients reported complete disappearance of malaria symptoms within the course of the treatment and it was proposed that the bioavailability of artemisinin from the tea preparations may exceed that from pure artemisinin tablets [9] .
Two additional interesting papers regarding clinical studies using traditional preparations appeared almost contemporarily in 2004. In the first investigation [10] , the patients received 1 L of preparation from 9 g leaves of a special cultivar of A. annua containing 1.39% artemisinin, which resulted in a content of 94.5 mg/L artemisinin, administered in five doses of 200 mL each per day. Even if the given dose of artemisinin was only 19% of the usual daily dose of artemisinin in adults [11] , peak plasma levels were 240±75ng/mL artemisinin, approximately 40% of the peak concentrations reported after intake of 500 mg artemisinin in the form of capsules. The data indicated that artemisinin was absorbed faster from herbal tea preparations than from oral solid dosage forms, but the bioavailability was similar [10] . The other study that appeared in 2004 used an herbal drug containing 1.4% artemisinin and the infusions (5 or 9 g/herb /L; artemisinin content 47 and 94 mg/L, respectively) were administered divided into four doses of 250 mL each. Even if there were a higher rate of recrudescence, most of the reported malaria symptoms either improved or resolved within three days after initiation of therapy, as expected for either an artemisinin or quinine treatment [12] . All these studies have pointed out that the presence of flavonoids in the phytocomplex can enhance either the bioavailability or the activity of artemisinin. Thus, experimental evidence from in vitro studies suggests that some flavonoids may enhance the action of artemisinin against P. falciparum [13] . In an attempt to find an optimal extraction method for both artemisinin and flavonoids, we have reported the best recovery with n-hexane to obtain complete extraction of artemisinin and most of the flavonoids [14] .
The aim of the present study was to analyze the qualitative and quantitative composition of different extracts of the aerial parts of a cultivar of A. annua (0.52% artemisinin) selected by the University of Campinas. The investigated extraction methods were several techniques of infusion and decoction The flavonoid structures were determined by combining the HPLC/DAD/MS data with those previously reported [15] . Artemisinin was identified by mass spectrometry as the peak at 17.90 min. n-Hexane can selectively and exhaustively extract both artemisinin and flavonoids and, for this reason, was considered as a standard for comparison with other preparations.
Very different yields and contents of artemisinin and flavonoids were found in the tested extracts, as reported in Tables 1 and 2 . Concerning the percentage of constituents in the n-hexane extract, artemisinin made up 12.8% and the total flavonoids 62.8%. In particular, the respective percentages of different flavonoids were 34.3% for casticin and chrysoplenetin, 9.4% for artemetin and 19.1% for eupatin. An additional peak was found in the tinctures and in aqueous preparations and identified as chrysosplenol-D by combining the HPLC/DAD/MS data with those previously reported [16] .
The qualitative profile of the two tinctures was similar, while both the content of flavonoids and artemisinin was highest in the 60% v/v tincture, as reported in Table 1 . The greater amount of ethanol in T60, compared with T40, increased the efficiency of the extraction.
The extraction efficiency for artemisinin was 40% and for flavonoids 29.5%.
However, for all constituents of A. annua, the tinctures showed a greater power of extraction in comparison to infusions and decoctions, when the amount of solvent used was greater. In addition, after the freeze-drying process of the tinctures, the obtained dried powder of crude extract showed good technological properties and could be very useful in the formulation of either capsules or extemporaneous preparations.
In the case of infusions and decoctions, the highest contents of artemisinin and flavonoids were obtained from samples I3, D2 and M with 57.5%, 35.9% and 41.0% for artemisinin, respectively, and 8.2%, 9.9% and 7.7% for flavonoids. Artemisinin is known to be heat-unstable and Table 2 shows that tea prepared by adding boiling water to the leaves without further heating (I3) yields higher artemisinin concentrations than if the leaves are boiled for several minutes (D2), according to literature data [9, 10] . No great differences were evidenced between infusion and decoction methods for flavonoid content, but an increase of extraction efficiency was obtained with filtration of the hot solution (I3 and D2). Also a microwave oven can represent a valid alternative method to extract the constituents of A. annua, in particular artemisinin.
Experimental
Chemicals: A sample of a selected high-yield cultivar of A. annua was provided by P.M.M. of the Universidade Estadual de Campinas (Brazil). The Brazilian hybrid plant was obtained according to the procedure carried out by MEDIPLANT [17] . The percentages of constituents of the herbal drug were artemisinin 0.52% and total flavonoids 2.6%.
Artemisinin was purchased from Sigma (SigmaAldrich S.r.l., Milan, Italy). Indena Research Laboratories (Settala, Milan, Italy) kindly provided the reference rutin trihydrate (batch no. K12408717, standard purity 88.17%, considering the content of residual solvents, moisture and amount of impurities), which was used for the calibration of polymethoxylated flavonoids.
All the solvents used for the extraction and HPLC analysis (MeOH, n-hexane, dichloromethane, and acetonitrile) were HPLC grade from Merck (Darmstadt, Germany); 85% formic acid was provided by Carlo Erba (Milan, Italy). Water was purified by a Milli-Q plus system from Millipore (Milford, MA).
Preparation of the n-hexane extract:
The dried aerial parts of a sweet wormwood sample were cut into small pieces with an Osterizer. Samples of 200 g material was exhaustively extracted at room temperature by maceration with 2 L of n-hexane for 72 h. The eluates were subsequently taken to dryness under reduced pressure to obtain the crude extract.
Preparation of the tinctures:
The dried aerial parts of a sweet wormwood sample were cut into small pieces with an Osterizer. Samples of 10 g of material were extracted at room temperature by maceration with 100 g of ethanol [either 40 or 60% v/v (samples T40 and T60)].
Preparation of the decoctions:
Sample D1: A 9 g sample of dried aerial parts of sweet wormwood was extracted with 1 L of boiling water, kept boiling for 5 min, then left to cool and filtered. Sample D2: A 9 g sample of dried aerial parts of sweet wormwood was extracted with 1 L of boiling water, kept boiling for 5 min and immediately filtered. Sample M: A 9 g sample of pieces of sweet wormwood was treated with 1 L of water, kept boiling for 5 min in a microwave oven, then left to cool and filtered. For analytical purposes, all the filtrates were lyophilized and provided 2.15 g, 2.09 g, and 3.16 g of dried product, respectively.
Preparation of the infusions: Sample 11: A 9 g sample of dried sweet wormwood was extracted with 1 L of boiling water, then left to cool and filtered. Sample 12: A 9 g sample of dried aerial parts of sweet wormwood was extracted with 1 L of boiling water, covered, then left to cool and filtered. Sample 13: A 9 g sample of dried aerial parts of sweet wormwood was extracted with 1 L of boiling water, then left to cool for 15 min and filtered. For analytical purposes, the filtrates were lyophilized, providing 2.04, 1.89 and 3.44 g of dried product, respectively. 
HPLC-DAD and HPLC-MS systems:
The HPLC analyses were performed using a HP 1100 Liquid Chromatograph (Agilent Technologies, Palo Alto, CA, USA) equipped with a HP 1040 Diode Array Detector (DAD), an automatic injector, an auto sampler, a column oven and managed by a HP 9000 workstation (Agilent Technologies, Palo Alto, CA, USA).
Separations were performed on a reversed phase column Purospher®Star RP-18, namely Hibar®. The HPLC system was interfaced with a HP 1100 MSD API-electrospray (Agilent Technologies, Palo Alto, CA, USA). The interface geometry, with an orthogonal position of the nebulizer with respect to the capillary inlet, allowed the use of analytical conditions similar to those of HPLC-DAD analysis. Mass spectrometry operating conditions were optimized in order to achieve maximum sensitivity values: gas temperature 350°C at a flow rate of 10 L/min, nebulizer pressure 30 p.s.i., quadrupole temperature 30°C, and capillary voltage 3500 V. Full scan spectra from m/z 100 to 800 in the positive ion mode were obtained (scan time 1 s).
A prepacked column RP (250 x 4.6 mm) with particle size 5 µm (Merck, Darmstadt, Germany) was employed. The eluents were A: water adjusted to pH 3.2 with formic acid; B: acetonitrile; C: methanol. The mobile phase is reported in Table 3 . The system was operated with oven temperature at 26 o C. Before HPLC analysis, each sample was filtered through a cartridge-type sample filtration unit with a polytetrafluoroethylene (PTFE) membrane (d = 13 mm, porosity 0.45 µm, (Lida Manufacturing Corp.) and immediately injected.
Chromatograms were recorded between 200 and 450 nm. DAD spectra were stored for all peaks exceeding a threshold of 0.1 mAu.
Calibration curves:
A calibration curve, obtained from a methanolic solution of artemisinin (1 mg/mL), was used to quantify artemisinin in n-hexane extracts and tinctures, while a methanolic solution of artemisinin (0.5 mg/mL) was employed to determine the artemisinin content of infusions and decoctions. The flavonoid amounts were quantified by a methanolic solution of rutin international standard 0.03 mg/mL.
Sample analysis: Samples of 5 mg of the different extracts were accurately weighed and suspended in methanol (1.0 mL). The suspensions were sonicated for 10 min and filtered through a cartridge-type sample filtration unit before HPLC analysis. The tinctures were injected as prepared.
